chr22-17181877-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The ENST00000399837.8(ADA2):āc.1385T>Cā(p.Ile462Thr) variant causes a missense change. The variant allele was found at a frequency of 0.0000886 in 1,614,098 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ). Synonymous variant affecting the same amino acid position (i.e. I462I) has been classified as Likely benign.
Frequency
Consequence
ENST00000399837.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ADA2 | NM_001282225.2 | c.1385T>C | p.Ile462Thr | missense_variant | 9/10 | ENST00000399837.8 | NP_001269154.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ADA2 | ENST00000399837.8 | c.1385T>C | p.Ile462Thr | missense_variant | 9/10 | 1 | NM_001282225.2 | ENSP00000382731 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000499 AC: 76AN: 152158Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000103 AC: 26AN: 251460Hom.: 0 AF XY: 0.0000883 AC XY: 12AN XY: 135898
GnomAD4 exome AF: 0.0000465 AC: 68AN: 1461822Hom.: 0 Cov.: 33 AF XY: 0.0000413 AC XY: 30AN XY: 727208
GnomAD4 genome AF: 0.000493 AC: 75AN: 152276Hom.: 0 Cov.: 33 AF XY: 0.000443 AC XY: 33AN XY: 74454
ClinVar
Submissions by phenotype
Sneddon syndrome;C3887654:Vasculitis due to ADA2 deficiency Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Feb 25, 2022 | - - |
Vasculitis due to ADA2 deficiency Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 18, 2022 | This sequence change replaces isoleucine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 462 of the ADA2 protein (p.Ile462Thr). This variant is present in population databases (rs61744537, gnomAD 0.1%). This variant has not been reported in the literature in individuals affected with ADA2-related conditions. ClinVar contains an entry for this variant (Variation ID: 566003). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on ADA2 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
ADA2-related disorder Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | May 09, 2023 | The ADA2 c.1385T>C variant is predicted to result in the amino acid substitution p.Ile462Thr. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.14% of alleles in individuals of African descent in gnomAD (http://gnomad.broadinstitute.org/variant/22-17662767-A-G). Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at